Detail akcie Agilent Tech online

Business Summary: Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
Financial Summary: BRIEF: For the fiscal year ended 31 October 2024, Agilent Technologies Inc revenues decreased 5% to $6.51B. Net income increased 4% to $1.29B. Revenues reflect Life Sciences and Applied Markets segment decrease of 17% to $3.22B, Asia Pacific segment decrease of 8% to $2.17B, United States segment decrease of 6% to $2.57B. Net Income benefited from Agilent CrossLab segment income increase of 13% to $524M.